MedPath

Controlled human cross-over intervention trial to demonstrate the bioactivity of Tropaeolum majus (nasturtium) - pilot study

Not Applicable
Conditions
health promoting potentialHealthy volunteers
Registration Number
DRKS00016548
Lead Sponsor
niversitätsklinikum FreiburgInstitut für Infektionsprävention und KrankenhaushygieneMolekulare Präventivmedizin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
41
Inclusion Criteria

healthy, non-smokers

Exclusion Criteria

acute and chronic diseases, acute peptic ulcer, acute nephritis, pregnancy, breastfeeding, taking antibiotics (acute, during the last three months), known allergy to Cruciferous vegetables and BMI> 25 or <18.5

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
anti-inflammatory potential of nasturtium, before and after intervention, by PGE2 measurement in the blood and peripheral immune cells, which are isolated from blood with and without stimulation in vitro.
Secondary Outcome Measures
NameTimeMethod
Alteration of inflammatory markers in the respiratory air condensate, modification of the composition of the gut microbiota (totality of colonizing microorganisms), release of signaling molecules, and the determination of BITC / metabolites and other phytochemicals before and after the intervention.
© Copyright 2025. All Rights Reserved by MedPath